Regulatory Risk

Regulatory bureaucracy is now a primary risk factor for AI chip manufacturers, with State Department licensing delays directly impacting NVIDIA's revenue potential in China. This creates a new layer of operational risk beyond traditional supply chain issues.

FDA regulatory processes are becoming increasingly unpredictable due to political interference and internal turnover, leading to inconsistent approval standards for gene therapies.

Ratepayer protection mechanisms vary significantly by state. In many jurisdictions, residential customers may bear the cost of underutilized data center infrastructure.

The ongoing investigation of Jerome Powell introduces political risk into the Fed confirmation process, potentially compromising the institution's perceived independence. This could affect market confidence and global perceptions of U.S. economic stability.

The Carbon Border Adjustment Mechanism (CBAM) creates a significant asymmetry, as Indian goods face carbon taxes in the EU while EU goods enter India duty-free. This undermines the net benefit of the deal for Indian heavy industry.